What is the appropriate next step in evaluating a 49‑year‑old woman with persistent dysuria and vulvar inflammation, given negative STI testing and normal hormone levels?

Perform a Detailed Pelvic Examination to Identify Vulvar Dermatoses or Pelvic Floor Pathology

In a 49-year-old woman with persistent dysuria and vulvar inflammation despite negative STI testing and normal hormones, the next step is a comprehensive pelvic examination specifically evaluating for vulvar dermatoses (lichen sclerosus, lichen planus, contact dermatitis), urethral pathology (urethral diverticulum, Skene's gland abnormalities), pelvic floor muscle tenderness, and bladder pain syndrome. 1, 2

Algorithmic Approach to Evaluation

Step 1: Detailed Pelvic Examination Components

The examination must systematically assess:

• Vulvar skin inspection: Look for dermatologic lesions including pallor, erosions, fissures, lichenification, or scarring that suggest lichen sclerosus, lichen planus, or other inflammatory dermatoses 3, 4
• Urethral palpation: Assess for urethral diverticulum, urethritis, or Skene's gland enlargement/cysts 1
• Vestibular examination: Check for tenderness at the vestibular glands and introitus, noting pain with speculum insertion 2
• Pelvic floor muscle assessment: Palpate for trigger point tenderness in pelvic floor muscles during bimanual examination 2
• Bladder palpation: Rule out bladder distension or suprapubic tenderness 2

Step 2: Obtain Urine Studies

Despite negative STI testing, you need:

• Urinalysis with microscopy: Look for pyuria (>5 WBC/hpf) to confirm or exclude urinary inflammation 1
• Urine culture: Even with negative STI testing, bacterial cystitis must be ruled out with proper culture 1
• Consider testing for ureaplasma and chlamydia if pyuria is present with negative standard cultures 2

Step 3: Implement Bladder Diary

Have the patient complete a 3-day frequency-volume chart. Patients with bladder pain syndrome characteristically void small volumes frequently, with first morning void indicating functional bladder capacity 2. This distinguishes bladder pain syndrome from other causes.

Step 4: Biopsy When Indicated

If vulvar lesions are identified on examination, perform vulvar biopsy to distinguish inflammatory conditions from premalignant or malignant processes 4. This is critical because vulvar dermatoses share overlapping symptoms with genitourinary syndrome of menopause but require entirely different treatment approaches 3.

Critical Clinical Reasoning

The 2026 AUA/CUA/SUFU guideline emphasizes that dysuria has multiple non-infectious causes including atrophic vaginitis, pelvic floor myofascial pain, and vulvar lichen sclerosus 1. The specificity of dysuria for UTI is only well-established in young women without vaginal symptoms—this 49-year-old with vulvar inflammation falls outside that narrow population 1.

The presence of vulvar inflammation is a red flag that shifts the differential away from simple UTI toward:

• Vulvar dermatoses (lichen sclerosus, lichen planus, contact dermatitis)
• Bladder pain syndrome with associated vulvodynia
• Pelvic floor dysfunction
• Urethral pathology

Common Pitfalls to Avoid

1. Do not assume normal hormones exclude genitourinary syndrome of menopause: While less likely, GSM can occur with normal serum hormone levels due to local tissue factors 3

2. Do not miss vulvar dermatoses: These are frequently misdiagnosed as recurrent infections or GSM, leading to delayed appropriate treatment 3

3. Do not overlook bladder pain syndrome: The 2017 RCOG guideline notes that 97% of BPS patients have pain worsened by certain foods/drinks and/or bladder filling, improved with urination 2

4. Do not rely solely on patient history: Physical examination findings are essential—the location, morphology, and distribution of vulvar lesions guide diagnosis 3, 4

When to Refer

Refer to dermatology or a vulvar specialist if you identify:

• Diagnostic uncertainty after initial evaluation
• Scarring or functional impairment
• Refractory disease despite initial treatment
• Multisite mucocutaneous involvement 3

The structured approach combining targeted pelvic examination, urinalysis, bladder diary, and selective biopsy will identify the underlying cause in this patient with persistent symptoms despite negative initial testing.